Bernhard Kirschbaum

Director/Board Member at REDX PHARMA LIMITED

67 year

Health Technology

Consumer Services

Miscellaneous

Profile

Bernhard Kirschbaum's current job(s) include being the Chairman at OMEICOS Therapeutics GmbH, an Independent Non-Executive Director at Redx Pharma Plc, a Director at BioMedx Group, Inc., a Scientific Advisor at FutuRx Ltd., a Member-Supervisory Board at BioMed X GmbH, and a Member-Supervisory Board at Amarna Therapeutics BV since 2019.
Dr. Kirschbaum's former job(s) include being the Chairman-Supervisory Board at Protagen AG, a Research Director at Merck Serono SA from 2005 to 2012, a Director at Enlivex Therapeutics Ltd., a Director at KAHR Medical Ltd., an Independent Director at Enlivex Therapeutics Ltd., a Principal at Institut Pasteur, a Principal at The Rockefeller University, and a Vice President-Discovery Research at Sanofi-Aventis Deutschland GmbH.
Dr. Kirschbaum obtained a doctorate degree from Universität Konstanz in 1989.

Bernhard Kirschbaum active positions

Companies	Position	Start
REDX PHARMA LIMITED	Director/Board Member	2015-12-31
OMEICOS Therapeutics GmbH OMEICOS Therapeutics GmbH BiotechnologyHealth Technology Develops small molecules using endogenous protective mechanism for the treatment and prevention of atrial fibrillation	Chairman	-
BioMedx Group, Inc. BioMedx Group, Inc. Medical SpecialtiesHealth Technology Develops photo-realistic 3-D and holographic digital human modeling devices for medical and healthcare industry	Director/Board Member	-
Amarna Therapeutics BV Amarna Therapeutics BV Medical/Nursing ServicesHealth Services Develops gene and immune-therapies	Director/Board Member	2019-10-15
BioMed X GmbH BioMed X GmbH Miscellaneous Commercial ServicesCommercial Services Engages in research and development in oncology, neuroscience, respiratory medicine, microbiology and diagnostics	Director/Board Member	-
FutuRx Ltd. FutuRx Ltd. Investment ManagersFinance FutuRx invests in companies located in Israel. The firm focuses on sectors such as health technology and technology services with an investment size of ILS 3 million. It participates in seed stage transactions and also makes follow on investment.	Consultant / Advisor	-

All active positions of Bernhard Kirschbaum

Former positions of Bernhard Kirschbaum

Companies	Position	End
KAHR Medical Ltd. KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology Develops immunotherapeutic drugs	Director/Board Member	-
Enlivex Therapeutics Ltd. /Old/ Enlivex Therapeutics Ltd. /Old/ Medical SpecialtiesHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions	Director/Board Member	-
ENLIVEX	Director/Board Member	-
░░░░░░░░ ░░░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-
░░░ ░░░░░░░░░░░ ░░░░░░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-

See the detail of Bernhard Kirschbaum's experience

Training of Bernhard Kirschbaum

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Bernhard Kirschbaum's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	15
Institut Pasteur Institut Pasteur Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment	Miscellaneous
The Rockefeller University The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Sanofi-Aventis Deutschland GmbH Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products & provides research and development services	Health Technology
Universität Konstanz Universität Konstanz Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Merck Serono SA Merck Serono SA Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for reproductive and metabolism	Health Technology
Protagen AG Protagen AG BiotechnologyHealth Technology Specializes in the development of novel diagnostic and companion diagnostic tests	Health Technology
Enlivex Therapeutics Ltd. /Old/ Enlivex Therapeutics Ltd. /Old/ Medical SpecialtiesHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions	Health Technology
KAHR Medical Ltd. KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology Develops immunotherapeutic drugs	Health Technology
Redx Pharma Plc Redx Pharma Plc Pharmaceuticals: MajorHealth Technology Discovers and develops novel, small molecule & targeted therapeutics for treatment of cancer and fibrotic disease	Health Technology
OMEICOS Therapeutics GmbH OMEICOS Therapeutics GmbH BiotechnologyHealth Technology Develops small molecules using endogenous protective mechanism for the treatment and prevention of atrial fibrillation	Health Technology
FutuRx Ltd. FutuRx Ltd. Investment ManagersFinance FutuRx invests in companies located in Israel. The firm focuses on sectors such as health technology and technology services with an investment size of ILS 3 million. It participates in seed stage transactions and also makes follow on investment.	Finance
BioMedx Group, Inc. BioMedx Group, Inc. Medical SpecialtiesHealth Technology Develops photo-realistic 3-D and holographic digital human modeling devices for medical and healthcare industry	Health Technology
BioMed X GmbH BioMed X GmbH Miscellaneous Commercial ServicesCommercial Services Engages in research and development in oncology, neuroscience, respiratory medicine, microbiology and diagnostics	Commercial Services
Amarna Therapeutics BV Amarna Therapeutics BV Medical/Nursing ServicesHealth Services Develops gene and immune-therapies	Health Services
Enlivex Therapeutics Ltd. Enlivex Therapeutics Ltd. BiotechnologyHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions	Health Technology